I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Selinexor (KPT-330) has antitumor activity against anaplast..:
Garg, Manoj
;
Kanojia, Deepika
;
Mayakonda, Anand
...
qt52f072bm. , 2017
Link:
https://escholarship.org/uc/item/52f072bm
RT Journal T1
Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt52f072bm&Exemplar=1&LAN=DE A1 Garg, Manoj A1 Kanojia, Deepika A1 Mayakonda, Anand A1 Ganesan, Trivadi S A1 Sadhanandhan, Bindhya A1 Suresh, Sidhanth A1 S, Sneha A1 Nagare, Rohit P A1 Said, Jonathan W A1 Doan, Ngan B A1 Ding, Ling-Wen A1 Baloglu, Erkan A1 Shacham, Sharon A1 Kauffman, Michael A1 Koeffler, H Phillip PB eScholarship, University of California YR 2017 K1 Tumor Cells K1 Cultured K1 Animals K1 Humans K1 Thyroid Neoplasms K1 Disease Models K1 Animal K1 Hydrazines K1 Triazoles K1 Doxorubicin K1 Karyopherins K1 Receptors K1 Cytoplasmic and Nuclear K1 Antineoplastic Agents K1 Treatment Outcome K1 Neoplasm Transplantation K1 Apoptosis K1 Models K1 Biological K1 Cell Cycle Checkpoints K1 Heterografts K1 Thyroid Carcinoma K1 Anaplastic K1 Clinical Research K1 Cancer K1 Rare Diseases K1 Aetiology K1 2.1 Biological and endogenous factors JF qt52f072bm LK http://dx.doi.org/https://escholarship.org/uc/item/52f072bm DO https://escholarship.org/uc/item/52f072bm SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)